Cephalon Faces Class Cert. Bid In Actiq Marketing Row
Two companies that chip in for employees' prescription drugs sought class certification last week in a Pennsylvania suit against Cephalon over off-label marketing for the painkiller Actiq, saying the fact that...To view the full article, register now.
Already a subscriber? Click here to view full article